Skip to main content

Table 3 Independent predictors of health utilities in Japanese patients (p < 0.05 only)

From: Health utilities using SF-6D scores in Japanese patients with chronic hepatitis C treated with sofosbuvir-based regimens in clinical trials

Predictor Beta Std. Err. p
Age ≥ 60 years −4.18 0.94 <0.0001
Male gender 3.15 0.94 <0.0001
Insomnia −6.10 1.38 <0.0001
Treatment regimen (interacted with time – end of treatment only)
LDV/SOF reference
LDV/SOF + RBV −5.33 1.32 <0.0001
SOF + RBV −4.06 1.36 0.0030